1-3 of 3
Christiane Houde, BS
Close
Save search
Sort by
Journal Articles

A Phase II Multicenter Single Arm Study of Ibrutinib in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Free
Radhakrishnan Ramchandren, MD, Tycel J. Phillips, MD, Sumana Devata, MD, Ali M. Gabali, MD PhD, Christiane Houde, BS, Silva Pregja, MBA, Golbon Aghamohammadi, MSN,ANP-BC, Emily Wesson, NP, Tony Hutto, BS, Michelle A. Fanale, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1527.
https://doi.org/10.1182/blood.V130.Suppl_1.1527.1527
Published: 2017
Journal Articles

Phase I Trial of Pomalidomide, Bortezomib, and Dexamethasone As Frontline Treatment of AL Amyloidosis

Free
Jeffrey A Zonder, MD, Vaishali Sanchorawala, MD, Vishal Kukreti, MD FRCP(C), Sascha A Tuchman, MD, Yubin Kang, MD, Divaya Bhutani, MD, Steven Burt, ANP, Christiane Houde, BS, Kathy A. Reichel, Silva Pregja, MBA, Jeffrey V Matous, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3158.
https://doi.org/10.1182/blood.V130.Suppl_1.3158.3158
Published: 2017
Journal Articles

A Phase I Trial of Pomalidomide, Bortezomib (Velcade), and Dexamethasone (PVD) As Initial Treatment of AL Amyloidosis and Light Chain Deposition Disease

Free
Jeffrey Zonder, MD, Christiane Houde, BS, Sascha Tuchman, MD, Vishal Kukreti, MD, Vaishali Sanchorawala, MD, Silva Pregja, MBA, Kathy A Reichel, Steven M Burt, NP, Colleen Neveux, RN, Jeffrey Matous, MD
Journal: Blood
Blood (2014) 124 (21): 4767.
https://doi.org/10.1182/blood.V124.21.4767.4767
Published: 2014